Advancing breakthrough therapies for patients with serious diseases that have no/limited options. Founder & CEO of biotherapeutics company PureTech (NASDAQ/LSE: PRTC). 27 new therapeutics initiated by our team, 16 in clinical testing and 2 cleared for marketing by FDA and other regulatory agencies Pronouns: She/her